Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

Median time to pain improvement and the impact of baseline pain severity on pain response in patients with psoriatic arthritis treated with tofacitinib

<br><strong>Background </strong>Pain is a core domain of psoriatic arthritis (PsA). This post hoc analysis evaluated time to pain improvement and the impact of baseline pain severity on pain response in patients with PsA receiving tofacitinib. <br><strong> Methods </...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	de Vlam, K, Ogdie, A, Bushmakin, AG, Cappelleri, JC, Fleischmann, R, Taylor, PC, Azevedo, V, Fallon, L, Woolcott, J, Mease, PJ
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	BMJ Publishing Group 2021

Những quyển sách tương tự

Median time to pain improvement in patients with psoriatic arthritis treated with tofacitinib
Bằng: de Vlam, K, et al.
Được phát hành: (2018)

Baseline pain severity as a predictor of pain improvement following treatment with tofacitinib in psoriatic arthritis
Bằng: Ogdie, A, et al.
Được phát hành: (2018)

Identifying and quantifying the role of inflammation in pain reduction for patients with psoriatic arthritis treated with tofacitinib: a mediation analysis
Bằng: de Vlam, K, et al.
Được phát hành: (2022)

Understanding mediators of pain reduction in psoriatic arthritis patients treated with tofacitinib: role of inflammation
Bằng: Taylor, P, et al.
Được phát hành: (2019)

Identifying mediators of pain reduction in patients with psoriatic arthritis treated with tofacitinib: Role of inflammation associated with peripheral arthritis, enthesitis and skin disease
Bằng: Taylor, PC, et al.
Được phát hành: (2020)

The effect of tofacitinib on residual pain in patients with psoriatic arthritis
Bằng: Dougados, M, et al.
Được phát hành: (2020)

Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
Bằng: Iain B McInnes, et al.
Được phát hành: (2020-02-01)

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
Bằng: Dougados, M, et al.
Được phát hành: (2022)

The effect of tofacitinib on residual pain in patients with rheumatoid arthritis and psoriatic arthritis
Bằng: Maxime Dougados, et al.
Được phát hành: (2022-11-01)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
Bằng: Gladman, DD, et al.
Được phát hành: (2022)

Itch as major mediator of effect of tofacitinib on health-related quality of life in psoriatic arthritis: a mediation analysis
Bằng: Taylor, PC, et al.
Được phát hành: (2021)

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in Phase 3 studies of tofacitinib
Bằng: Coates, L, et al.
Được phát hành: (2021)

Pain and inflammation as mediators of tofacitinib treatment effect on fatigue in patients with ankylosing spondylitis: a mediation analysis
Bằng: Kristensen, LE, et al.
Được phát hành: (2023)

Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Bằng: Philip J. Mease, et al.
Được phát hành: (2024-01-01)

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
Bằng: Taylor, P, et al.
Được phát hành: (2022)

Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis
Bằng: Daniela Graham, et al.
Được phát hành: (2021-04-01)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
Bằng: Dafna D. Gladman, et al.
Được phát hành: (2022-02-01)

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in phase 3 studies of tofacitinib
Bằng: Laura C. Coates, et al.
Được phát hành: (2021-03-01)

Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies
Bằng: Peter C. Taylor, et al.
Được phát hành: (2022-07-01)

Measuring outcomes in psoriatic arthritis
Bằng: Ogdie, A, et al.
Được phát hành: (2020)

Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Bằng: Alexis Ogdie, et al.
Được phát hành: (2024-09-01)

Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
Bằng: Lars Erik Kristensen, et al.
Được phát hành: (2023-06-01)

Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
Bằng: Nash, P, et al.
Được phát hành: (2020)

Psoriatic arthritis
Bằng: FitzGerald, O, et al.
Được phát hành: (2021)

Time to improvement of pain, morning stiffness, fatigue, and disease activity in patients with ankylosing spondylitis treated with tofacitinib: a post hoc analysis
Bằng: Victoria Navarro-Compán, et al.
Được phát hành: (2024-05-01)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
Bằng: Ogdie, A, et al.
Được phát hành: (2023)

Psoriatic arthritis - Tofacitinib as a new treatment
Bằng: Marta Skorupska, et al.
Được phát hành: (2024-06-01)

Pain reduction in patients with rheumatoid arthritis receiving tofacitinib monotherapy with or without pain medication: A post hoc analysis of pooled data from phase 2, phase 3 and phase 3B/4 studies
Bằng: Taylor, PC, et al.
Được phát hành: (2019)

Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs
Bằng: Philip J Mease, et al.
Được phát hành: (2019-06-01)

Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors in the phase III, randomised controlled trial: OPAL Beyond
Bằng: Philip J Mease, et al.
Được phát hành: (2019-06-01)

Itch as the major mediator of the effect of tofacitinib on health-related quality of life in PSA: a mediation analysis
Bằng: Taylor, P, et al.
Được phát hành: (2020)

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs
Bằng: Kevin L. Winthrop, et al.
Được phát hành: (2022-12-01)

Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
Bằng: Lars E. Kristensen, et al.
Được phát hành: (2023-02-01)

Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study
Bằng: Nash, P, et al.
Được phát hành: (2021)

Post-marketing safety surveillance of tofacitinib over 9 years in patients with psoriatic arthritis and rheumatoid arthritis
Bằng: Burmester, GR, et al.
Được phát hành: (2023)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
Bằng: Ly K, et al.
Được phát hành: (2019-08-01)

Efficacy of tofacitinib for the treatment of psoriatic arthritis: pooled analysis of two phase 3 studies
Bằng: Nash, P, et al.
Được phát hành: (2018)

Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Bằng: Gerd R. Burmester, et al.
Được phát hành: (2023-07-01)

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
Bằng: Peter Nash, et al.
Được phát hành: (2018-11-01)

Classification and outcome measures for psoriatic arthritis
Bằng: Leung, Y, et al.
Được phát hành: (2018)